Zhejiang Benli Technology Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Benli Technology Co., Ltd. is a national high-tech enterprise focused on the field of chemical intermediates. It is committed to the research and development, production, and sales of pharmaceutical intermediates, pesticide intermediates, and new material intermediates. It always adheres to innovation as the driving force, and develops safe, environmentally friendly, and economical synthesis processes to replace traditional processes in response to the pain points and difficulties in the application field of chemical intermediates, It is a professional chemical intermediate production enterprise in China that focuses on clean production. We have strong competitive advantages in research and development, technical service capabilities, stable supply capabilities, and brand influence. The company has outstanding research and development capabilities, strong independent innovation capabilities, and possesses multiple patents and non patented technologies, including 20 invention patents and more than 10 utility model patents. It has undertaken multiple major scientific research projects. In 2016, it successively won honors such as the "First Prize for Science and Technology Progress in Zhejiang Province", the "First Prize for Science and Technology Progress in the China Petroleum and Chemical Federation", and the "First Prize for Innovation and Cooperation Achievements in China's Industry University Research". The company focuses on the research of green process routes for quinolone raw materials and key intermediates, and has established technical platforms such as carbon monoxide carbonylation reaction, carbon tetrachloride Foucault reaction, and green synthesis of quinolone raw materials. The industrialization of key intermediates such as 801 and 1201 products has been achieved, and the production processes of some quinolone raw materials have been unified on a large platform through the above-mentioned key intermediates, effectively solving the problem of high usage of toxic and harmful raw materials The high production volume and high production costs of the "three wastes" industry have created conditions for the large-scale, cyclic, continuous, and automated production of quinolone raw materials and key intermediates. The company's 801 and 1201 products have been individually or jointly applied to more than ten quinolone raw materials, including ofloxacin, levofloxacin, ciprofloxacin, enrofloxacin, and norfloxacin. With the extension of process substitution, they will be applied to more quinolone raw materials in the future. In addition to the application of pharmaceutical intermediates, the company has also expanded the application of 801 product to the field of pesticide intermediates, and has successfully developed new production processes for some pesticide intermediates and new material intermediates using three major technology platforms, replacing and transforming traditional processes. It has begun to enter the fields of pesticide fungicides, insecticides, herbicides, photoinitiators for new materials, and pharmaceutical cephalosporins, and the application fields of products and technologies are gradually expanding. For more than a decade, Benli Technology has practiced the corporate spirit of "putting a gentleman at the center, and relying on the principle of" innovation, substitution, and cost ", adhering to the business philosophy of" innovation, substitution, and cost ". We have taken the responsibility of providing cost-effective chemical intermediates to the industry, implemented differentiation strategies, and replaced traditional craftsmanship with innovative processes. Around the three major technological platforms, we have selected some products and key intermediate production processes in the fields of medicine, pesticides, new materials, and other fields for substitution and transformation, Continuously expanding the application fields of products and technologies, further extending the industrial chain, establishing a continuous innovation mechanism, maintaining strong innovation vitality, and continuously expanding the company's scale and enhancing its profitability through deep integration of new processes, products, and industries. We strive tirelessly to develop the enterprise, achieve employee success, serve customers, and give back to society. |
| Headquarter | Taizhou |
| Establish Date | 5/13/2011 |
| Listed Code | 301065.SZ |
| Listed Date | 9/14/2021 |
| Chairman | Wu Zhengjie. |
| CEO | Wu Zhengjie. |
| Website | www.benlitech.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
